Add BrightSurf on Google Email

Search results for “Parasites”

1,000+ results for "Parasites"

NIH-supported researchers identify new class of malaria compounds

Researchers identified a new class of anti-malarial compounds, 4-(1 H )-quinolone-3-diarylethers, derived from endochin, which effectively treats malaria in birds. The compounds demonstrated strong activity against Plasmodium falciparum and Plasmodium vivax, the parasites responsible for most human cases of malaria.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalScience Translational Medicine·DateMar 20, 2013

New tool in the fight against tropical diseases

A novel screening method using genetically engineered baker's yeast identifies chemical compounds that target disease-causing parasites without harming human hosts. The approach has shown promise in identifying potential anti-parasitic compounds with high sensitivity, reducing costs, and increasing reproducibility.

SourceUniversity of Cambridge·JournalOpen Biology·DateFeb 26, 2013

Chloroquine makes comeback to combat malaria

Scientists have observed that chloroquine is once again effective in combating malaria parasites, particularly in Senegal and other African countries. This development could lead to more affordable treatment options for millions of people in Africa, with the current treatment costing twice as much as chloroquine.

SourceUniversity of Copenhagen·JournalAmerican Journal of Tropical Medicine and Hygiene·DateOct 3, 2012

JCI early table of contents for Sept. 10, 2012

Researchers develop a human liver-chimeric mouse model to study malaria parasites and understand human host/parasite interactions. Additionally, studies reveal the link between serum ferritin levels and insulin sensitivity, as well as the role of granulocyte-colony stimulating factor in protecting against influenza infection.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 10, 2012

Lifestyle of a killer

Researchers found Hematodinium sp. and its sister species are a major problem for crab fisheries, causing 'bitter crab' disease. The parasites have bacteria-like endosymbionts that increase their chances of survival outside the shrimp, leading to significant damage to infected crustaceans.

SourceBMC (BioMed Central)·JournalAquatic Biosystems·DateSep 6, 2012

Research could lead to new drugs for major diseases

Researchers at the University of Gothenburg are working on developing substances that can prevent parasites, bacteria, and fungi from producing essential proteins. If successful, this could lead to the development of new drugs for several major diseases, including cancer, parasitic diseases, and bacterial and fungal infections.

SourceUniversity of Gothenburg·JournalTetrahedron·DateJun 11, 2012

Richer parasite diversity leads to healthier frogs, says University of Colorado study

A University of Colorado study found that increases in parasite diversity lead to a decrease in the infection success rate of virulent parasites, including one that causes malformed limbs and premature death. Higher biodiversity can help protect against certain diseases by acting as a buffer against virulent pathogens.

SourceUniversity of Colorado at Boulder·JournalProceedings of the National Academy of Sciences·DateMay 21, 2012

Fruit flies use alcohol as a drug to kill parasites

A recent study by Emory University found that fruit flies infected with blood-borne parasites consume alcohol to increase their survival rate. The researchers discovered that the toxic effects of alcohol can be protective against infectious disease and raise an important question about whether other organisms, including humans, could c...

SourceEmory Health Sciences·JournalCurrent Biology·DateFeb 16, 2012

Different paths to drug resistance in Leishmania

Researchers found that Leishmania parasites have almost identical DNA sequences within species populations, suggesting a small number of genes cause different symptoms. The parasite's evolutionary success may be driven by genetic abnormalities leading to copy number variation, which increases understanding of drug resistance mechanisms.

SourceWellcome Trust Sanger Institute·JournalGenome Research·DateOct 27, 2011